Core Scientific (NASDAQ:CORZ) Sets New 52-Week High Following Analyst Upgrade

Core Scientific, Inc. (NASDAQ:CORZ)’s stock price reached a new 52-week high on Monday after B. Riley raised their price target on the stock from $13.00 to $14.00. B. Riley currently has a buy rating on the stock. Core Scientific traded as high as $13.40 and last traded at $13.40, with a volume of 194991 shares changing hands. The stock had previously closed at $13.22.

Several other equities analysts have also recently commented on the stock. Canaccord Genuity Group began coverage on shares of Core Scientific in a research report on Monday, September 23rd. They set a “buy” rating and a $16.00 price target on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $20.00 price objective on shares of Core Scientific in a research note on Thursday, October 3rd. Canaccord Genuity Group initiated coverage on shares of Core Scientific in a research note on Monday, September 23rd. They set a “buy” rating and a $16.00 price objective on the stock. BTIG Research increased their price objective on shares of Core Scientific from $10.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, June 26th. Finally, LADENBURG THALM/SH SH reiterated a “buy” rating and set a $14.50 price objective on shares of Core Scientific in a research note on Tuesday, July 2nd. Eleven analysts have rated the stock with a buy rating, According to MarketBeat.com, Core Scientific has an average rating of “Buy” and a consensus price target of $15.27.

Insider Buying and Selling at Core Scientific

In other news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the completion of the transaction, the chief financial officer now directly owns 122,217 shares in the company, valued at $1,150,061.97. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the completion of the transaction, the chief financial officer now directly owns 122,217 shares in the company, valued at $1,150,061.97. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $108,986.62. Following the completion of the transaction, the insider now owns 1,686,474 shares of the company’s stock, valued at $15,869,720.34. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 12,761 shares of company stock worth $127,080. 32.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Creative Planning boosted its holdings in Core Scientific by 88.0% during the third quarter. Creative Planning now owns 32,925 shares of the company’s stock worth $389,000 after buying an additional 15,413 shares in the last quarter. ORG Wealth Partners LLC bought a new stake in Core Scientific during the third quarter worth approximately $106,266,000. Rise Advisors LLC boosted its holdings in Core Scientific by 14.3% during the third quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock worth $95,000 after buying an additional 1,000 shares in the last quarter. Shikiar Asset Management Inc. bought a new stake in Core Scientific during the third quarter worth approximately $889,000. Finally, LifePro Asset Management bought a new stake in Core Scientific during the third quarter worth approximately $2,019,000.

Core Scientific Trading Down 1.9 %

The stock’s fifty day moving average is $10.90 and its two-hundred day moving average is $8.07.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, August 7th. The company reported ($4.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($4.47). The company had revenue of $141.10 million for the quarter, compared to analysts’ expectations of $128.58 million. The firm’s revenue was up 11.2% compared to the same quarter last year. On average, equities research analysts predict that Core Scientific, Inc. will post 0.01 EPS for the current fiscal year.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.